Official american thoracic society technical standards: Spirometry in the occupational setting

American Journal of Respiratory and Critical Care Medicine

Volumn 189, Issue 8, 2014, Pages 984-994

  Redlich, Carrie A ^a   Tarlo, Susan M ^a   Hankinson, John L ^a   Townsend, Mary C ^a   Eschenbacher, William L ^a   Von Essen, Susanna G ^a   Sigsgaard, Torben ^a   Weissman, David N ^a  

^a Society of Thoracic Surgeons   (United States)

Author keywords

FEV1; Longitudinal spirometry; Medical surveillance; Occupational; Spirometry

Indexed keywords

ARTICLE; ASIAN; ASIAN AMERICAN; ASTHMA; BODY POSTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; ETHNIC DIFFERENCE; EVIDENCE BASED PRACTICE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FITNESS; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENDER; HEALTH HAZARD; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; MEDICAL EDUCATION; MEDICAL SOCIETY; NORTH AMERICA; OCCUPATIONAL EXPOSURE; OCCUPATIONAL SAFETY; PERIODIC MEDICAL EXAMINATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY CONTROL; RACE DIFFERENCE; REFERENCE VALUE; REFRESHER COURSE; SITTING; SMOKING; SPIROMETER; SPIROMETRY; STANDING; SYSTEMATIC REVIEW; WEIGHT GAIN; WORKER; WORKPLACE; EVIDENCE BASED MEDICINE; HEALTH SURVEY; LUNG DISEASE; OCCUPATIONAL DISEASE; OCCUPATIONAL MEDICINE; STANDARD; UNITED STATES; AGING; DISEASE EXACERBATION; EMBASE; MEDLINE;

ASTHMA; EVIDENCE-BASED MEDICINE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; OCCUPATIONAL MEDICINE; POPULATION SURVEILLANCE; POSTURE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY FIBROSIS; REFERENCE VALUES; SPIROMETRY; UNITED STATES;

EID: 84899032944     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201402-0337st     Document Type: Article

References (100)

1. Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, et al.; ATS/ERS Task Force. General considerations for lung function testing. Eur Respir J 2005;26:153-161.
2. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al.; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J 2005;26: 319-338.
3. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26: 948-968.
4. Townsend MC; American College of Occupational and Environmental Medicine. ACOEM position statement: spirometry in the occupational setting. J Occup Environ Med 2000;42:228-245.
5. Townsend MC. Evaluating pulmonary function change over time in the occupational setting. J Occup Environ Med 2005;47:1307-1316.
6. Townsend MC; Occupational and Environmental Lung Disorders Committee. Spirometry in the occupational health setting- 2011 update. J Occup Environ Med 2011;53:569-584.
7. OSHA. Spirometry testing in occupational health programs: best practices for healthcare professionals. OSHA publication no. 3637-2013; 2013 [accessed 2013 Sep 16]. Available from: http://www.osha.gov/Publications/OSHA3637.pdf
8. National Institute for Occupational Safety and Health. NIOSH spirometry training guide. DHHS (NIOSH) publication no. 2004-154c; 2003 [accessed 2013 Sep 16]. Available from: http://www.cdc.gov/niosh/docs/2004-154c/pdfs/2004-154c.pdf
9. US National Archives and Records Administration. Code of federal regulations. Title 29, Part 1910.1043 Cotton dust; 2012 [accessed 2013 Sep 16]. Available from: https://www.osha.gov/pls/oshaweb/owadisp.show-document?p-table= STANDARDS&p-id=10053
10. US National Archives and Records Administration. Code of federal regulations. Title 29, Part 1910.1001. Asbestos; 2012 [accessed 2013 Sep 16]. Available from: https://www.osha.gov/pls/oshaweb/owadisp.show-document?p-table= STANDARDS&p-id=9995
11. US National Archives and Records Administration. Code of federal regulations. Title 29, Part 1910.1028. Benzene; 2012 [accessed 2013 Sep 16]. Available from: https://www.osha.gov/pls/oshaweb/owadisp.show-document?p-table= STANDARDS&p-id=10042
12. Steenbruggen I, Mitchell S, Severin T, Palange P, Cooper BG; Spirometry HERMES Task Force. Harmonising spirometry education with HERMES: training a new generation of qualified spirometry practitioners across Europe. Eur Respir J 2011;37:479-481.
13. Bellia V, Pistelli R, Catalano F, Antonelli-Incalzi R, Grassi V, Melillo G, Olivieri D, Rengo F. Quality control of spirometry in the elderly: the SA.R.A. study. SAlute Respiration nell'Anziano = Respiratory Health in the Elderly. Am J Respir Crit Care Med 2000;161:1094-1100.
14. Borg BM, Hartley MF, Fisher MT, Thompson BR. Spirometry training does not guarantee valid results. Respir Care 2010;55:689-694.
15. Burton MA, Burton DL, Simpson MD, Gissing PM, Bowman SL. Respiratory function testing: the impact of respiratory scientists on the training and support of primary health care providers. Respirology 2004;9:260-264.
16. den Otter JJ, Knitel M, Akkermans RP, van Schayck CP, Folgering HT, van Weel C. Spirometry in general practice: the performance of practice assistants scored by lung function technicians. Br J Gen Pract 1997;47:41-42. (see comment).
17. Eaton T, Withy S, Garrett JE, Mercer J, Whitlock RML, Rea HH. Spirometry in primary care practice: the importance of quality assurance and the impact of spirometry workshops. Chest 1999;116: 416-423.
18. Enright PL, Johnson LR, Connett JE, Voelker H, Buist AS. Spirometry in the Lung Health Study. 1. Methods and quality control. Am Rev Respir Dis 1991;143:1215-1223.
19. Enright P, Skloot G, Herbert R. Standardization of spirometry in assessment of responders following man-made disasters: World Trade Center worker and volunteer medical screening program. Mt Sinai J Med 2008;75:109-114.
20. Enright PL, Skloot GS, Cox-Ganser JM, Udasin IG, Herbert R. Quality of spirometry performed by 13,599 participants in the World Trade Center Worker and Volunteer Medical Screening Program. Respir Care 2010;55:303-309.
21. Hankinson JL, Bang KM. Acceptability and reproducibility criteria of the American Thoracic Society as observed in a sample of the general population. Am Rev Respir Dis 1991;143:516-521.
22. Kunzli N, Ackermann-Liebrich U, Keller R, Perruchoud AP, Schindler C; Swiss Study on Air Pollution and Lung Disease in Adults. Variability of FVC and FEV1 due to technician, team, device and subject in an eight centre study: three quality control studies in SAPALDIA. Eur Respir J 1995;8:371-376.
23. Latzke-Davis B, Stout J, Smith K, Solomon C, Garrison M, Mangione- Smith R. Effectiveness of Spirometry Fundamentals™ for increasing the proper use of spirometry in patients with asthma and COPD. Prim Care Respir J 2011;20:441-447.
24. Malmstrom K, Peszek I, Al Botto, Lu S, Enright PL, Reiss TF. Quality assurance of asthma clinical trials. Control Clin Trials 2002;23: 143-156.
25. Pé rez-Padilla R, Vá zquez-Garćia JC, Má rquez MN, Menezes AM; PLATINO Group. Spirometry quality-control strategies in a multinational study of the prevalence of chronic obstructive pulmonary disease. Respir Care 2008;53:1019-1026.
26. Schermer TR, Jacobs JE, Chavannes NH, Hartman J, Folgering HT, Bottema BJ, van Weel C. Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD). Thorax 2003;58:861-866.
27. Schermer TR, Akkermans RP, Crockett AJ, van Montfort M, Grootens- Stekelenburg J, Stout JW, Pieters W. Effect of e-learning and repeated performance feedback on spirometry test quality in family practice: a cluster trial. Ann Fam Med 2011;9:330-336.
28. Silverman RA, Flaster E, Enright PL, Simonson SG. FEV1 performance among patients with acute asthma: results from a multicenter clinical trial. Chest 2007;131:164-171. (see comment).
29. Stoller JK, Buist AS, Burrows B, Crystal RG, Fallat RJ, McCarthy K, Schluchter MD, Soskel NT, Zhang R. Quality control of spirometry testing in the registry for patients with severe alpha1-antitrypsin deficiency: Alpha1-Antitrypsin Deficiency Registry Study Group. Chest 1997;111:899-909.
30. Stoller JK, Orens DK, Hoisington E, McCarthy K. Bedside spirometry in a tertiary care hospital: the Cleveland clinic experience. Respir Care 2002;47:578-582.
31. Townsend MC, Morgan J, Durkin D, DuChene AG, Lamb S. Quality control aspects of pulmonary function testing in the Multiple Risk Factor Intervention Trial. Control Clin Trials 1986; 7(3, Suppl) 179S-192S.
32. Upton MN, Ferrell C, Bidwell C, McConnachie A, Goodfellow J, Davey Smith G, Watt GC. Improving the quality of spirometry in an epidemiological study: the Renfrew-Paisley (Midspan) family study. Public Health 2000;114:353-360.
33. Walters JA, Hansen EC, Johns DP, Blizzard EL, Walters EH, Wood- Baker R. A mixed methods study to compare models of spirometry delivery in primary care for patients at risk of COPD. Thorax 2008;63: 408-414.
34. Yawn BP, Enright PL, Lemanske RF Jr., Israel E, Pace W, Wollan P, Boushey H. Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD. Chest 2007;132:1162-1168.
35. Fiz JA, Aguilar X, Carreres A, Barbany M, Formiguera X, Izquierdo J, Morera J. Postural variation of the maximum inspiratory and expiratory pressures in obese patients. Int J Obes 1991;15:655-659.
36. Gudmundsson G, Cerveny M, Shasby DM. Spirometric values in obese individuals: effects of body position. Am J Respir Crit Care Med 1997;156:998-999.
37. Lalloo UG, Becklake MR, Goldsmith CM. Effect of standing versus sitting position on spirometric indices in healthy subjects. Respiration 1991;58:122-125.
38. Lin F, Parthasarathy S, Taylor SJ, Pucci D, Hendrix RW, Makhsous M. Effect of different sitting postures on lung capacity, expiratory flow, and lumbar lordosis. Arch Phys Med Rehabil 2006;87:504-509.
39. Pierson DJ, Dick NP, Petty TL. A comparison of spirometric values with subjects in standing and sitting positions. Chest 1976;70:17-20.
40. Razi E, Moosavi GA. The effect of positions on spirometric values in obese asthmatic patients. Iran J Allergy Asthma Immunol 2007;6: 151-154.
41. Townsend MC. Spirometric forced expiratory volumes measured in the standing versus the sitting posture. Am Rev Respir Dis 1984;130: 123-124.
42. Roberts SD, Farber MO, Knox KS, Phillips GS, Bhatt NY, Mastronarde JG, Wood KL. FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest 2006;130:200-206.
43. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-187.
44. Kiefer EM, Hankinson JL, Barr RG. Similar relation of age and height to lung function among whites, African Americans, and Hispanics. Am J Epidemiol 2011;173:376-387.
45. Fulambarker A, Copur AS, Javeri A, Jere S, Cohen ME. Reference values for pulmonary function in Asian Indians living in the United States. Chest 2004;126:1225-1233.
46. Hankinson JL, Kawut SM, Shahar E, Smith LJ, Stukovsky KH, Barr RG. Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the Multi-Ethnic Study of Atherosclerosis (MESA) lung study. Chest 2010;137:138-145.
47. Korotzer B, Ong S, Hansen JE. Ethnic differences in pulmonary function in healthy nonsmoking Asian-Americans and European- Americans. Am J Respir Crit Care Med 2000;161:1101-1108.
48. Lin FL, Kelso JM. Pulmonary function studies in healthy Filipino adults residing in the United States. J Allergy Clin Immunol 1999;104: 338-340.
49. Marcus EB, MacLean CJ, Curb JD, Johnson LR, Vollmer WM, Buist AS. Reference values for FEV1 in Japanese-American men from 45 to 68 years of age. Am Rev Respir Dis 1988;138:1393-1397.
50. Massey DG, Fournier-Massey G. Japanese-American pulmonary reference values: influence of environment on anthropology and physiology. Environ Res 1986;39:418-433.
51. Sharp DS, Enright PL, Chiu D, Burchfiel CM, Rodriguez BL, Curb JD. Reference values for pulmonary function tests of Japanese- American men aged 71 to 90 years. Am J Respir Crit Care Med 1996; 153:805-811.
52. Ip MSM. Lung function testing in health and disease: issues pertaining to Asia-Pacific populations. Respirology 2011;16:190-197.
53. Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, et al.; ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur Respir J 2012;40:1324-1343.
54. Kumar R, Seibold MA, Aldrich MC, Williams LK, Reiner AP, Colangelo L, Galanter J, Gignoux C, Hu D, Sen S, et al. Genetic ancestry in lung-function predictions. N Engl J Med 2010;363:321-330.
55. Kiviranta K, Haahtela T. Caucasian race and lung function: time to revisit the racial groups used in reference values. Eur Respir J 2006;28:1280. (Pubitemid 44883867)
56. Hankinson JL, Wagner GR. Medical screening using periodic spirometry for detection of chronic lung disease. Occup Med 1993;8:353-361.
57. Hnizdo E, Yu L, Freyder L, Attfield M, Lefante J, Glindmeyer HW. The precision of longitudinal lung function measurements: monitoring and interpretation. Occup Environ Med 2005;62:695-701.
58. Hnizdo E, Sircar K, Glindmeyer HW, Petsonk EL. Longitudinal limits of normal decline in lung function in an individual. J Occup Environ Med 2006;48:625-634.
59. Hnizdo E, Sircar K, Yan T, Harber P, Fleming J, Glindmeyer HW. Limits of longitudinal decline for the interpretation of annual changes in FEV1 in individuals. Occup Environ Med 2007;64:701-707.
60. Hnizdo E. The value of periodic spirometry for early recognition of longterm excessive lung function decline in individuals. J Occup Environ Med 2012;54:1506-1512.
61. Johnsen HL, Hetland SM, Benth JS, Kongerud J, Søyseth V. Dust exposure assessed by a job exposure matrix is associated with increased annual decline in FEV1: a 5-year prospective study of employees in Norwegian smelters. Am J Respir Crit Care Med 2010;181:1234-1240.
62. McKay RT, LeMasters GK, Hilbert TJ, Levin LS, Rice CH, Borton EK, Lockey JE. A long term study of pulmonary function among US refractory ceramic fibre workers. Occup Environ Med 2011;68:89-95.
63. Hnizdo E, Berry A, Hakobyan A, Beeckman-Wagner LA, Catlett L. Worksite wellness program for respiratory disease prevention in heavy-construction workers. J Occup Environ Med 2011;53:274-281.
64. Burchfiel CM, Marcus EB, Sharp DS, Enright PL, Rodriguez BL, Masaki KH, Hwang LJ, Curb JD. Characteristics associated with rapid decline in forced expiratory volume. Ann Epidemiol 1996;6:217-227.
65. Burrows B, Lebowitz MD, Camilli AE, Knudson RJ. Longitudinal changes in forced expiratory volume in one second in adults: methodologic considerations and findings in healthy nonsmokers. Am Rev Respir Dis 1986;133:974-980.
66. Kohansal R, Martinez-Camblor P, Agust́i A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med 2009;180:3-10.
67. Siedlinski M, Postma DS, Boer JM, van der Steege G, Schouten JP, Smit HA, Boezen HM. Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population. Respir Res 2009;10:73.
68. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-1648.
69. Sherrill DL, Enright P, Cline M, Burrows B, Lebowitz MD. Rates of decline in lung function among subjects who restart cigarette smoking. Chest 1996;109:1001-1005.
70. Lee PN, Fry JS. Systematic review of the evidence relating FEV1 decline to giving up smoking. BMC Med 2010;8:84.
71. Thyagarajan B, Jacobs DR Jr., Apostol GG, Smith LJ, Jensen RL, Crapo RO, Barr RG, Lewis CE, Williams OD. Longitudinal association of body mass index with lung function: the CARDIA study. Respir Res 2008;9:31.
72. Wang ML, Avashia BH, Petsonk EL. Interpreting longitudinal spirometry: weight gain and other factors affecting the recognition of excessive FEV1 decline. Am J Ind Med 2009;52:782-789.
73. Wang ML, McCabe L, Hankinson JL, Shamssain MH, Gunel E, Lapp NL, Banks DE. Longitudinal and cross-sectional analyses of lung function in steelworkers. Am J Respir Crit Care Med 1996;153: 1907-1913.
74. Beeckman LA, Wang ML, Petsonk EL, Wagner GR. Rapid declines in FEV1 and subsequent respiratory symptoms, illnesses, and mortality in coal miners in the United States. Am J Respir Crit CareMed 2001;163:633-639.
75. Baughman P, Marott JL, Lange P, Andrew M, Hnizdo E. Health outcomes associated with lung function decline and respiratory symptoms and disease in a community cohort. COPD 2011;8:103-113.
76. Ryan G, Knuiman MW, Divitini ML, James A, Musk AW, Bartholomew HC. Decline in lung function and mortality: the Busselton Health Study. J Epidemiol Community Health 1999;53:230-234.
77. Sircar K, Hnizdo E, Petsonk EL, Attfield M. Decline in lung function and mortality: implications for medical monitoring. Occup Environ Med 2007;64:461-466.
78. Wang ML, Avashia BH, Wood J, Petsonk EL. Excessive longitudinal FEV1 decline and risks to future health: a case-control study. Am J Ind Med 2009;52:909-915.
79. Glindmeyer HW, Jones RN, Diem JE, Weill H. Useful and extraneous variability in longitudinal assessment of lung function. Chest 1987; 92:877-882.
80. Wang ML, McCabe L, Petsonk EL, Hankinson JL, Banks DE. Weight gain and longitudinal changes in lung function in steel workers. Chest 1997;111:1526-1532.
81. Bottai M, Pistelli F, Di Pede F, Carrozzi L, Baldacci S, Matteelli G, Scognamiglio A, Viegi G. Longitudinal changes of body mass index, spirometry and diffusion in a general population. Eur Respir J 2002;20:665-673.
82. Hnizdo E, Glindmeyer HW, Petsonk EL. Workplace spirometry monitoring for respiratory disease prevention: a methods review. Int J Tuberc Lung Dis 2010;14:796-805.
83. Berry G. Longitudinal observations: their usefulness and limitations with special reference to the forced expiratory volume. Bull Physiopathol Respir (Nancy) 1974;10:643-656.
84. Halperin WE, Ratcliffe J, Frazier TM, Wilson L, Becker SP, Schulte PA. Medical screening in the workplace: proposed principles. J Occup Med 1986;28:547-552.
85. Harber P, Levine J, Bansal S. How frequently should workplace spirometry screening be performed? Optimization via analytic models. Chest 2009;136:1086-1094.
86. Matte TD, Fine L, Meinhardt TJ, Baker EL. Guidelines for medical screening in the workplace. Occup Med 1990;5:439-456.
87. Wang ML, Avashia BH, Petsonk EL. Interpreting periodic lung function tests in individuals: the relationship between 1- to 5-year and longterm FEV1 changes. Chest 2006;130:493-499.
88. Chaisson NF, Kreiss K, Hnizdo E, Hakobyan A, Enright PL. Evaluation of methods to determine excessive decline of forced expiratory volume in one second in workers exposed to diacetyl-containing flavorings. J Occup Environ Med 2010;52:1119-1123.
89. United States Department of Health and Human Services (DHHS) USPHS, Centers for Disease Control and Prevention, National Institute of Occupational Safety and Health (NIOSH). Medical screening and surveillance program for underground and surface coal miners. In: Criteria for a recommended standard: occupational exposure to respirable coal mine dust. Cincinnati: DHHS (NIOSH); 1995. DHHS (NIOSH) Publication No. 95-106. Section 1.4, pp. 4-5.
90. Seixas NS, Robins TG, Attfield MD, Moulton LH. Longitudinal and cross sectional analyses of exposure to coal mine dust and pulmonary function in new miners. Br J Ind Med 1993;50:929-937.
91. Wang ML, Wu ZE, Du QG, Peng KL, Li YD, Li SK, Han GH, Petsonk EL. Rapid decline in forced expiratory volume in 1 second (FEV1) and the development of bronchitic symptoms among new Chinese coal miners. J Occup Environ Med 2007;49:1143-1148.
92. Wang ML, Wu ZE, Du QG, Petsonk EL, Peng KL, Li YD, Li SK, Han GH, Atffield MD. A prospective cohort study among new Chinese coal miners: the early pattern of lung function change. Occup Environ Med 2005;62:800-805.
93. Wang ML, Petsonk EL. Repeatedmeasures of FEV1 over six to twelvemonths: what change is abnormal? J Occup Environ Med 2004;46:591-595.
94. National Institute for Occupational Safety and Health. Spirometry Longitudinal Data Analysis (Spirola) software [created 2008 Jun 30; last revised 2012 Sep 10; accessed 2013 Sep 16]. Available from: http://www.cdc.gov/niosh/ topics/spirometry/spirola-software.html
95. Hnizdo E, Hakobyan A, Fleming JL, Beeckman-Wagner LA. Periodic spirometry in occupational setting: improving quality, accuracy, and precision. J Occup Environ Med 2011;53:1205-1209.
96. Harber P, Barnhart S, Boehlecke BA, Beckett WS, Gerrity T, McDiarmid MA, Nardbell E, Repsher L, Brousseau L, Hodous TK, et al. Respiratory protection guidelines: this official statement of the American Thoracic Society was adopted by the ATS Board of Directors, March 1996. Am J Respir Crit Care Med 1996;154:1153-1165.
97. US National Archives and Records Administration. Code of federal regulations. Title 29, Part 1910.134. Respiratory protection; 2011 [accessed 2013 Sep 16]. Available from: https://www.osha.gov/pls/oshaweb/owadisp.show- document?p-table=STANDARDS&p-id=12716
98. Tarlo SM, Balmes J, Balkissoon R, Beach J, Beckett W, Bernstein D, Blanc PD, Brooks SM, Cowl CT, Daroowalla F, et al. Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement. Chest 2008; 134(3, Suppl)1S-41S.
99. California Department of Public Health, Health Evaluation System and Information Service, Occupational Health Branch. Medical surveillance for flavorings-related lung disease among flavor manufacturing workers in California; 2007 [updated 2012; accessed 2013 Sep 16]. Available from: http://www.cdph.ca.gov/programs/ohb/Documents/flavorguidelines. pdf
100. American Thoracic Society. Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med 2004;170:691-715.